Krop IE - Search Results

1

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.

Shu S, Lin CY, He HH, Witwicki RM, Tabassum DP, Roberts JM, Janiszewska M, Huh SJ, Liang Y, Ryan J, Doherty E, Mohammed H, Guo H, Stover DG, Ekram MB, Brown J, D'Santos C, Krop IE, Dillon D, McKeown M, Ott C, Qi J, Ni M, Rao PK, Duarte M, Wu SY, Chiang CM, Anders L, Young RA, Winer E, Letai A, Barry WT, Carroll JS, Long H, Brown M, Liu XS, Meyer CA, Bradner JE, Polyak K. Shu S, et al. Among authors: krop ie. Nature. 2016 Jan 21;529(7586):413-417. doi: 10.1038/nature16508. Epub 2016 Jan 6. Nature. 2016. PMID: 26735014 Free PMC article.

2

A SAGE (serial analysis of gene expression) view of breast tumor progression.

Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K. Porter DA, et al. Among authors: krop ie. Cancer Res. 2001 Aug 1;61(15):5697-702. Cancer Res. 2001. PMID: 11479200

3

Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression).

Seth P, Krop I, Porter D, Polyak K. Seth P, et al. Oncogene. 2002 Jan 24;21(5):836-43. doi: 10.1038/sj.onc.1205113. Oncogene. 2002. PMID: 11850811

4

Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.

Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, Johannsdottir HK, Nevanlinna H, Borg A, Gelman R, Barkardottir RB, Lindblom A, Polyak K. Krop I, et al. Cancer Res. 2003 May 1;63(9):2024-7. Cancer Res. 2003. PMID: 12727813

5

Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.

Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K. Krop I, et al. Mol Cancer Res. 2004 Sep;2(9):489-94. Mol Cancer Res. 2004. PMID: 15383627

6

Ovarian suppression for breast cancer: an effective treatment in search of a home.

Krop IE, Winer EP. Krop IE, et al. J Clin Oncol. 2005 Sep 1;23(25):5869-72. doi: 10.1200/JCO.2005.06.002. Epub 2005 Aug 8. J Clin Oncol. 2005. PMID: 16087947 No abstract available.

7

HIN-1, an inhibitor of cell growth, invasion, and AKT activation.

Krop I, Parker MT, Bloushtain-Qimron N, Porter D, Gelman R, Sasaki H, Maurer M, Terry MB, Parsons R, Polyak K. Krop I, et al. Cancer Res. 2005 Nov 1;65(21):9659-69. doi: 10.1158/0008-5472.CAN-05-1663. Cancer Res. 2005. PMID: 16266985

8

A putative role for psoriasin in breast tumor progression.

Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K. Krop I, et al. Cancer Res. 2005 Dec 15;65(24):11326-34. doi: 10.1158/0008-5472.CAN-05-1523. Cancer Res. 2005. PMID: 16357139

9

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M. Segara D, et al. Among authors: krop ie. J Surg Oncol. 2007 Nov 1;96(6):474-80. doi: 10.1002/jso.20856. J Surg Oncol. 2007. PMID: 17640031 Clinical Trial.

10

Ten years of HER2-directed therapy: still questions after all these years.

Krop IE, Winer EP. Krop IE, et al. Breast Cancer Res Treat. 2009 Jan;113(2):207-9. doi: 10.1007/s10549-008-0041-2. Epub 2008 May 8. Breast Cancer Res Treat. 2009. PMID: 18463974 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters